BeStock  
Stocks › Biotechnology › CLYM

Climb Bio CLYM

US equityMarket cap rank #3548Biotechnology
$9.19 −$0.09 (-0.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.03 -1.76%
Open$8.98
Prev close$9.28
Day range$8.90 – $9.40
Volume770.2K
Market cap$539.80M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$29.18+217.5% vs. price
  • Buy 100%
Low $23.00Now $9.19Avg $29.18High $40.00

Recent rating changes

The last 20 actions on file set price targets from $23.00 to $40.00, averaging $29.50.

DateFirmRatingTarget
10 Nov 2026 Freedom Capital Markets BUY $26.00
9 Nov 2026 H.C. Wainwright BUY $30.00
6 Nov 2026 Truist Financial BUY $25.00
6 Nov 2026 Wedbush BUY $27.00
5 Nov 2026 Guggenheim BUY $35.00
5 Nov 2026 RBC Capital BUY $23.00
4 Nov 2026 BTIG BUY $32.00
30 Oct 2026 Piper Sandler BUY $40.00
27 Oct 2026 Wedbush BUY $25.00
27 Oct 2026 H.C. Wainwright BUY $30.00
26 Oct 2026 Piper Sandler BUY $40.00
26 Oct 2026 Wedbush BUY $25.00
20 Oct 2026 Deutsche Bank BUY $28.00
13 Oct 2026 RBC Capital BUY $23.00
12 Oct 2026 H.C. Wainwright BUY $30.00
1 Oct 2026 BTIG BUY $32.00
8 Sep 2026 H.C. Wainwright BUY $30.00
4 Sep 2026 Truist Financial BUY –
4 Sep 2026 B. Riley Securities BUY $30.00
3 Sep 2026 William Blair BUY –

Discussion

No comments yet — be the first to weigh in on CLYM.

Sign in to join the discussion.

Scroll to Top